3. Umbruch 4.4..2005 - Online Pot

228 F. Barth and M. Rinaldi-Carmona
Kosel B, Aberg JA et al. (2003) Short-Term Effects of Cannabinoids in Patients with HIV-1
Infection: A Randomized, Placebo-Controlled Clinical Trial. Ann Intern Med 139: 258–266
15 Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral
[delta]9-THC. Physiol Behav 65: 343–346
16 Koch JE (2001) [Delta]9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and
sweet high-fat diets. Pharmacol Biochem Behav 68: 539–543
17 Miller CC, Murray TF, Freeman KG, Edwards GL (2004) Cannabinoid agonist, CP 55,940, facilitates
intake of palatable foods when injected into the hindbrain. Physiol Behav 80: 611–616
18 Giuliani D, Ottani A, Ferrari F (2000) Effects of the cannabinoid receptor agonist, HU 210, on
ingestive behaviour and body weight of rats. Eur J Pharmacol 391: 275–279
19 Graceffo TJ, Robinson JK (1998) Delta-9 tetrahydrocannabinol (THC) fails to stimulate sonsumption
of a highly palatable food in the rat. Life Sci 62: L85–L88
20 Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid
(CB1) receptors. Psychopharmacology 143: 315–317
21 Hao S, Avraham Y, Mechoulam R, Berry EM (2000) Low dose anandamide affects food intake,
cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J
Pharmacol 392: 147–156
22 Jamshidi N, Taylor DA (2001) Anandamide administration into the ventromedial hypothalamus
stimulates appetite in rats. Brit J Pharmacol 134: 1151–1154
23 Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic
forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by
2-arachidonoyl glycerol. Brit J Pharmacol 136: 550–557
24 Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following
administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370: 233–240
25 Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R (2001) Critical role of the
endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol 419:
207–214
26 Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R (2003)
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a
“CB3” receptor. Eur J Pharmacol 461: 27–34
27 Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani
J, Neliat G, Caput D, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain
cannabinoid receptor. FEBS Lett 350: 240–244
28 Williams CM, Kirkham TC (2002) Reversal of [Delta]9-THC hyperphagia by SR141716 and
naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71: 333–340
29 Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective
inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1)
receptors. Psychopharmacology 132: 104–106
30 Simiand J, Keane M, Keane PE, Soubrie P (1998) SR141716, a CB1 cannabinoid receptor antagonist,
selectively reduces sweet food intake in marmoset. Behavi Pharmacol 9: 179–181
31 Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998) Appetite suppression and
weight loss after the cannabinoid antagonist SR141716. Life Sci 63: L113–L117
32 Freedland CS, Sharpe AL, Samson HH, Porrino LJ (2001) Effects of SR141716A on ethanol and
sucrose self-administration. Alcohol Clin Exp Res 25: 277–282
33 Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, Soubrie P (2003)
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J
Physiol Regul Integr Comp Physiol 284: R345–R353
34 Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Antiobesity effects of chronic cannabinoid
CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462: 125–132
35 Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD,
Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food
intake. Nature 410: 822–825
36 Armone M, Millet L, Maffrand JP, Soubrié P (2004) Rimonabant reduces weight gain in obese
zucker rats by regulating hyperphagia and activating fatty acid oxidation. In: Abstracts of the 13th
European Congress on Obesity (ECO), Prague, Czech Republic, 26–29 May 2004. Int J Obes
Relat Metab Disord 28(Suppl. 1): 77
37 Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Pério A, Poncelet M, Maruani J,
Arnone M, Finance O et al. (2004) SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-